Depakote is indicated for treatment of manic episodes associated with bipolar disorder. Depakote ER Extended-Release Tablets are indicated for acute treatment
DEPAKOTE and DEPAKOTE ER are indicated for prophylaxis of migraine headaches. There is no evidence that DEPAKOTE ER or DEPAKOTE is useful in the acute treatment
Depakote and Depakote ER, broadens the indication of Depakote ER, omits indication statement, Please see full Indications on
Divalproex sodium (Depakote, Depakote ER, Depakote Sprinkles) View full drug information. Divalproex sodium is indicated for monotherapy or
Depakote is indicated for treatment of manic episodes associated with bipolar disorder. Depakote ER Extended-Release Tablets are indicated for acute treatment
Depakote – valproic acid/divalproex (View the FDA label) INDICATION AND USES: Depakote is an anti-epileptic drug indicated for:
Depakote – valproic acid/divalproex (View the FDA label) INDICATION AND USES: Depakote is an anti-epileptic drug indicated for:
Depakote is indicated for treatment of manic episodes associated with bipolar disorder. Depakote ER Extended-Release Tablets are indicated for acute treatment
Depakote is indicated for treatment of manic episodes associated with bipolar disorder. Depakote ER Extended-Release Tablets are indicated for acute treatment
Comments